{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T18:19:46Z","timestamp":1788718786280,"version":"build-2803163510"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K24224"],"award-info":[{"award-number":["JP23K24224"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K27499"],"award-info":[{"award-number":["JP23K27499"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007312","name":"National Center for Geriatrics and Gerontology","doi-asserted-by":"publisher","award":["21\\u201313"],"award-info":[{"award-number":["21\\u201313"]}],"id":[{"id":"10.13039\/501100007312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007312","name":"National Center for Geriatrics and Gerontology","doi-asserted-by":"publisher","award":["24\\u201320"],"award-info":[{"award-number":["24\\u201320"]}],"id":[{"id":"10.13039\/501100007312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.nbd.2024.106694","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T18:18:48Z","timestamp":1728152328000},"page":"106694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Decreased plasma nicotinamide and altered NAD+ metabolism in glial cells surrounding A\u03b2 plaques in a mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"202","author":[{"given":"Michiko","family":"Sekiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachie","family":"Chikamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimi","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Nishijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi M.","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2024.106694_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110848","article-title":"Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: a review of metabolomic evidence","volume":"128","author":"Amidfar","year":"2024","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106694_bb0010","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41467-020-14959-w","article-title":"Sex and APOE epsilon4 genotype modify the Alzheimer's disease serum metabolome","volume":"11","author":"Arnold","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2024.106694_bb0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2024.106694_bb0020","series-title":"Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology","author":"Ashton","year":"2024"},{"key":"10.1016\/j.nbd.2024.106694_bb0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fonc.2020.00358","article-title":"NAMPT and NAPRT: two metabolic enzymes with key roles in inflammation","volume":"10","author":"Audrito","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.nbd.2024.106694_bb0030","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jpba.2011.02.001","article-title":"Capillary electrophoresis as a metabolomics tool for non-targeted fingerprinting of biological samples","volume":"55","author":"Barbas","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.nbd.2024.106694_bb0035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2024.106694_bb0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1212\/WNL.0b013e31822a2791","article-title":"Glycine and its synaptic interactions: functional and clinical implications","volume":"77","author":"Benarroch","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2024.106694_bb0045","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2024.106694_bb0050","first-page":"401","article-title":"Neuroinflammation biomarkers in the AT(N) framework across the Alzheimer's disease continuum","volume":"10","author":"Bieger","year":"2023","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.nbd.2024.106694_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12263-017-0582-2","article-title":"Amino acid supplements and metabolic health: a potential interplay between intestinal microbiota and systems control","volume":"12","author":"Bifari","year":"2017","journal-title":"Genes Nutr."},{"key":"10.1016\/j.nbd.2024.106694_bb0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.24425","article-title":"Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model","volume":"78","author":"Blacher","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2024.106694_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106312","article-title":"Non-invasive biomarkers for mild cognitive impairment and Alzheimer's disease","volume":"187","author":"Botello-Marabotto","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2024.106694_bb0070","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41590-019-0336-y","article-title":"Inflammatory macrophage dependence on NAD(+) salvage is a consequence of reactive oxygen species-mediated DNA damage","volume":"20","author":"Cameron","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.nbd.2024.106694_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106694_bb0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuroscience.2017.05.022","article-title":"NAMPT inhibitor protects ischemic neuronal injury in rat brain via anti-neuroinflammation","volume":"356","author":"Chen","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2024.106694_bb0085","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-019-1150-2","article-title":"NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling","volume":"569","author":"Chowdhry","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2024.106694_bb0090","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a000588","article-title":"Metabolomics: an emerging but powerful tool for precision medicine","volume":"1","author":"Clish","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud."},{"key":"10.1016\/j.nbd.2024.106694_bb0095","doi-asserted-by":"crossref","first-page":"1067296","DOI":"10.3389\/fmolb.2022.1067296","article-title":"Nicotinamide as potential biomarker for Alzheimer\u2019s disease: a translational study based on metabolomics","volume":"9","author":"Dalmasso","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.nbd.2024.106694_bb0100","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.dadm.2017.07.006","article-title":"Blood-based metabolic signatures in Alzheimer\u2019s disease","volume":"8","author":"de Leeuw","year":"2017","journal-title":"Alzheimers Dement (Amst)."},{"key":"10.1016\/j.nbd.2024.106694_bb0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2024.106694_bb0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neurobiolaging.2022.04.009","article-title":"Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer's disease biomarkers","volume":"117","author":"Dong","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2024.106694_bb0115","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01794-22","article-title":"Longitudinal analysis of the microbiome and metabolome in the 5xfAD mouse model of Alzheimer\u2019s disease","volume":"13","author":"Dunham","year":"2022","journal-title":"mBio"},{"issue":"1118\u20131136","key":"10.1016\/j.nbd.2024.106694_bb0120","article-title":"SARM1 is a metabolic sensor activated by an increased NMN\/NAD(+) ratio to trigger axon degeneration","volume":"109","author":"Figley","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2024.106694_bb0125","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3233\/JAD-181189","article-title":"Serum metabolite markers of dementia through quantitative NMR analysis: the importance of threonine-linked metabolic pathways","volume":"69","author":"Figueira","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2024.106694_bb0130","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/acel.12216","article-title":"Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons","volume":"13","author":"Ghosh","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.nbd.2024.106694_bb0135","doi-asserted-by":"crossref","first-page":"1591S","DOI":"10.1093\/jn\/135.6.1591S","article-title":"Interrelationship between physical activity and branched-chain amino acids","volume":"135","author":"Gleeson","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.nbd.2024.106694_bb0140","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.neurobiolaging.2012.12.005","article-title":"Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-gamma coactivator 1alpha regulated beta-secretase 1 degradation and mitochondrial gene expression in Alzheimer\u2019s mouse models","volume":"34","author":"Gong","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2024.106694_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","article-title":"Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease","volume":"107","author":"Gonzalez-Dominguez","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.nbd.2024.106694_bb0150","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jpba.2015.01.025","article-title":"Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP\/PS1 transgenic model of Alzheimer\u2019s disease","volume":"107","author":"Gonzalez-Dominguez","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.nbd.2024.106694_bb0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biochi.2015.01.005","article-title":"Deciphering metabolic abnormalities associated with Alzheimer's disease in the APP\/PS1 mouse model using integrated metabolomic approaches","volume":"110","author":"Gonzalez-Dominguez","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.nbd.2024.106694_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study","volume":"17","author":"Gordon","year":"2018","journal-title":"The Lancet Neurology."},{"key":"10.1016\/j.nbd.2024.106694_bb0165","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","article-title":"Nicotinamide restores cognition in Alzheimer\u2019s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau","volume":"28","author":"Green","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2024.106694_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00216-016-0003-1","article-title":"High-throughput and simultaneous quantitative analysis of homocysteine-methionine cycle metabolites and co-factors in blood plasma and cerebrospinal fluid by isotope dilution LC-MS\/MS","volume":"409","author":"Guiraud","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.nbd.2024.106694_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021643","article-title":"Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2024.106694_bb0180","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2024.106694_bb0185","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/glia.23139","article-title":"CD38 positively regulates postnatal development of astrocytes cell-autonomously and oligodendrocytes non-cell-autonomously","volume":"65","author":"Hattori","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2024.106694_bb0190","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3233\/JAD-230121","article-title":"Alzheimer's disease-related Phospho-Tau181 signals are localized to demyelinated axons of Parvalbumin-positive GABAergic interneurons in an app Knock-in mouse model of amyloid-beta pathology","volume":"93","author":"Hirota","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2024.106694_bb0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12986-018-0271-1","article-title":"Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements","volume":"15","author":"Holecek","year":"2018","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.nbd.2024.106694_bb0200","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-023-02443-z","article-title":"CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease","volume":"29","author":"Horie","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2024.106694_bb0205","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2011226118","article-title":"NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING","volume":"118","author":"Hou","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2024.106694_bb0210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40659-022-00379-1","article-title":"Abeta promotes CD38 expression in senescent microglia in Alzheimer's disease","volume":"55","author":"Hu","year":"2022","journal-title":"Biol. Res."},{"key":"10.1016\/j.nbd.2024.106694_bb0215","doi-asserted-by":"crossref","first-page":"1040476","DOI":"10.3389\/fnut.2022.1040476","article-title":"Decreased circulating branched-chain amino acids are associated with development of Alzheimer's disease in elderly individuals with mild cognitive impairment","volume":"9","author":"Ikeuchi","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.nbd.2024.106694_bb0220","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/alz.12484","article-title":"A metabolite panel that differentiates Alzheimer's disease from other dementia types","volume":"18","author":"Jia","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2024.106694_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41514-023-00098-1","article-title":"Quantification of localized NAD(+) changes reveals unique specificity of NAD(+) regulation in the hypothalamus","volume":"9","author":"Johnson","year":"2023","journal-title":"NPJ Aging."},{"key":"10.1016\/j.nbd.2024.106694_bb0230","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2024.106694_bb0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13041-020-0565-x","article-title":"Nicotinamide attenuates the decrease in dendritic spine density in hippocampal primary neurons from 5xFAD mice, an Alzheimer's disease animal model","volume":"13","author":"Kim","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.nbd.2024.106694_bb0240","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD(+) in Brain Aging and Neurodegenerative Disorders","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2024.106694_bb0245","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114408","article-title":"Blood-based biomarkers for Alzheimer's disease","volume":"14","author":"Leuzy","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nbd.2024.106694_bb0250","article-title":"Defect of branched-chain amino acid metabolism promotes the development of Alzheimer's disease by targeting the mTOR signaling","volume":"38","author":"Li","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.nbd.2024.106694_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101987","article-title":"Integrative metabolomics science in Alzheimer's disease: relevance and future perspectives","volume":"89","author":"Lista","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.nbd.2024.106694_bb0260","article-title":"Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2024.106694_bb0265","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.neurobiolaging.2012.11.020","article-title":"Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession","volume":"34","author":"Liu","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2024.106694_bb0270","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41401-019-0239-3","article-title":"Interplay between Alzheimer's disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP\/PS1 transgenic mice","volume":"40","author":"Liu","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.nbd.2024.106694_bb0275","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrc3557","article-title":"Serine, glycine and one-carbon units: cancer metabolism in full circle","volume":"13","author":"Locasale","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.nbd.2024.106694_bb0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12883-015-0272-x","article-title":"Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer\u2019s disease-relevant murine model","volume":"15","author":"Long","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.nbd.2024.106694_bb0285","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/jnc.14811","article-title":"Nicotinamide phosphoribosyltransferase secreted from microglia via exosome during ischemic injury","volume":"150","author":"Lu","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2024.106694_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101372","article-title":"Neuronal excitation\/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology","volume":"69","author":"Maestu","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.nbd.2024.106694_bb0295","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","article-title":"Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-an emerging role for gut microbiome","volume":"15","author":"MahmoudianDehkordi","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2024.106694_bb0300","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2024.106694_bb0305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nlm.2016.07.001","article-title":"Cognitive deficits in single app knock-in mouse models","volume":"135","author":"Masuda","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.nbd.2024.106694_bb0310","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of Plasma Neurofilament Light with Neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2024.106694_bb0315","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma Neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2024.106694_bb0320","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114022","article-title":"Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau","volume":"13","author":"Mattsson-Carlgren","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nbd.2024.106694_bb0325","doi-asserted-by":"crossref","first-page":"e1295","DOI":"10.1212\/WNL.0000000000006277","article-title":"Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease","volume":"91","author":"McDade","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2024.106694_bb0330","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211310119","article-title":"NAD(+) metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity","volume":"119","author":"Meyer","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2024.106694_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110830","article-title":"Metabolic profiling of Alzheimer's disease: untargeted metabolomics analysis of plasma samples","volume":"127","author":"Milos","year":"2023","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106694_bb0340","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.chroma.2007.02.065","article-title":"Metabolome analysis by capillary electrophoresis-mass spectrometry","volume":"1168","author":"Monton","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.nbd.2024.106694_bb0345","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-beta biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2024.106694_bb0350","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","article-title":"Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: relationship to neuroimaging and CSF biomarkers","volume":"15","author":"Nho","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2024.106694_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100125","article-title":"Characterising Alzheimer\u2019s disease through integrative NMR- and LC-MS-based metabolomics","volume":"12","author":"Nielsen","year":"2021","journal-title":"Metabol Open."},{"key":"10.1016\/j.nbd.2024.106694_bb0360","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/alz.12800","article-title":"Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer\u2019s disease brains","volume":"19","author":"Novotny","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2024.106694_bb0365","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-180325","article-title":"Glial fibrillary acidic protein in serum is increased in Alzheimer's disease and correlates with cognitive impairment","volume":"67","author":"Oeckl","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2024.106694_bb0370","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1039\/B714176A","article-title":"Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS","volume":"4","author":"Ohashi","year":"2008","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.nbd.2024.106694_bb0375","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3233\/JAD-220479","article-title":"Bifidobacterium breve MCC1274 supplementation increased the plasma levels of metabolites with potential anti-oxidative activity in APP Knock-in mice","volume":"89","author":"Ohno","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2024.106694_bb0380","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-142925","article-title":"A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer\u2019s disease","volume":"45","author":"Olazaran","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2024.106694_bb0385","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1039\/c0mb00141d","article-title":"Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia","volume":"7","author":"Ooga","year":"2011","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.nbd.2024.106694_bb0390","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2011.55","article-title":"Metabolome in progression to Alzheimer's disease","volume":"1","author":"Oresic","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106694_bb0400","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11357-023-00999-9","article-title":"A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment","volume":"46","author":"Orr","year":"2024","journal-title":"Geroscience"},{"key":"10.1016\/j.nbd.2024.106694_bb0405","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1038\/s41598-022-19670-y","article-title":"Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer's disease (from the Nakayama study)","volume":"12","author":"Ozaki","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2024.106694_bb0410","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamaneurol.2014.1358","article-title":"Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid beta-amyloid 42: a cross-validation study against amyloid positron emission tomography","volume":"71","author":"Palmqvist","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2024.106694_bb0415","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma Phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2024.106694_bb0420","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neurobiolaging.2015.11.014","article-title":"Alzheimer's disease-like pathology has transient effects on the brain and blood metabolome","volume":"38","author":"Pan","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2024.106694_bb0425","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2174\/1570159X16666180926123722","article-title":"Omics-based biomarkers for the early Alzheimer disease diagnosis and reliable therapeutic targets development","volume":"17","author":"Pena-Bautista","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.nbd.2024.106694_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23937\/2469-5858\/1510021","article-title":"Phase II clinical trial of nicotinamide for the treatment of mild to moderate Alzheimer\u2019s disease","volume":"3","author":"Phelan","year":"2017","journal-title":"Journal of Geriatric Medicine and Gerontology."},{"key":"10.1016\/j.nbd.2024.106694_bb0435","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41398-021-01202-3","article-title":"Serum D-serine levels are altered in early phases of Alzheimer's disease: towards a precocious biomarker","volume":"11","author":"Piubelli","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106694_bb0440","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jamaneurol.2022.3392","article-title":"Association of Donanemab Treatment with Exploratory Plasma Biomarkers in early symptomatic Alzheimer disease: a secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial","volume":"79","author":"Pontecorvo","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2024.106694_bb0445","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jalz.2016.08.003","article-title":"Association of blood lipids with Alzheimer's disease: a comprehensive lipidomics analysis","volume":"13","author":"Proitsi","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2024.106694_bb0450","doi-asserted-by":"crossref","first-page":"1103303","DOI":"10.3389\/fnut.2023.1103303","article-title":"Investigating the causal association between branched-chain amino acids and Alzheimer\u2019s disease: a bidirectional Mendelian randomized study","volume":"10","author":"Qian","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.nbd.2024.106694_bb0455","article-title":"Metabolomics in degenerative brain diseases","volume":"1773","author":"Quintero","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2024.106694_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111567","article-title":"Preclinical and clinical evidence of NAD(+) precursors in health, disease, and ageing","volume":"199","author":"Reiten","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.nbd.2024.106694_bb0465","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fncel.2019.00258","article-title":"Deletion of CD38 suppresses glial activation and Neuroinflammation in a mouse model of demyelination","volume":"13","author":"Roboon","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2024.106694_bb0470","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/jnc.15367","article-title":"Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD","volume":"158","author":"Roboon","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2024.106694_bb0475","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1038\/s41380-021-01068-3","article-title":"Brain cells derived from Alzheimer\u2019s disease patients have multiple specific innate abnormalities in energy metabolism","volume":"26","author":"Ryu","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106694_bb0480","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single app knock-in mouse models of Alzheimer\u2019s disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2024.106694_bb0485","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12868-019-0496-6","article-title":"Amyloid-beta plaque formation and reactive gliosis are required for induction of cognitive deficits in app knock-in mouse models of Alzheimer's disease","volume":"20","author":"Sakakibara","year":"2019","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2024.106694_bb0490","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3233\/JAD-210385","article-title":"Widespread reduced density of noradrenergic locus Coeruleus axons in the app Knock-in mouse model of amyloid-beta amyloidosis","volume":"82","author":"Sakakibara","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2024.106694_bb0495","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","article-title":"APP mouse models for Alzheimer's disease preclinical studies","volume":"36","author":"Sasaguri","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2024.106694_bb0500","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma beta-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2024.106694_bb0505","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1002\/alz.12961","article-title":"Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease","volume":"19","author":"Shi","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2024.106694_bb0510","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2024.106694_bb0515","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/pr034020m","article-title":"Quantitative metabolome analysis using capillary electrophoresis mass spectrometry","volume":"2","author":"Soga","year":"2003","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.nbd.2024.106694_bb0520","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1021\/ac900675k","article-title":"Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry","volume":"81","author":"Soga","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.nbd.2024.106694_bb0525","doi-asserted-by":"crossref","first-page":"14038","DOI":"10.1038\/s41598-017-14420-x","article-title":"Late-onset Alzheimer\u2019s disease is associated with inherent changes in bioenergetics profiles","volume":"7","author":"Sonntag","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2024.106694_bb0530","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature25143","article-title":"Enhancing mitochondrial proteostasis reduces amyloid-beta proteotoxicity","volume":"552","author":"Sorrentino","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2024.106694_bb0535","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JAD-210737","article-title":"Metabolomic alterations in the blood and brain in association with Alzheimer's disease: evidence from in vivo to clinical studies","volume":"84","author":"Sriwichaiin","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2024.106694_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111569","article-title":"The balance between NAD(+) biosynthesis and consumption in ageing","volume":"199","author":"Stromland","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.nbd.2024.106694_bb0545","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012921","article-title":"Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Abeta pathology are detected","volume":"12","author":"Suarez-Calvet","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nbd.2024.106694_bb0550","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","article-title":"Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles","volume":"6","author":"Sugimoto","year":"2010","journal-title":"Metabolomics"},{"key":"10.1016\/j.nbd.2024.106694_bb0555","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2024.106694_bb0560","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2024.106694_bb0565","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","article-title":"Metabolic network failures in Alzheimer\u2019s disease: a biochemical road map","volume":"13","author":"Toledo","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2024.106694_bb0570","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1038\/ncomms6101","article-title":"NAD+ protects against EAE by regulating CD4+ T-cell differentiation","volume":"5","author":"Tullius","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2024.106694_bb0575","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jalz.2018.01.003","article-title":"Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: a prospective study in eight cohorts","volume":"14","author":"Tynkkynen","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2024.106694_bb0580","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jalz.2017.11.012","article-title":"Circulating metabolites and general cognitive ability and dementia: evidence from 11 cohort studies","volume":"14","author":"van der Lee","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2024.106694_bb0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.nbd.2024.106694_bb0590","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD(+) in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.nbd.2024.106694_bb0595","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"The Lancet Neurology."},{"key":"10.1016\/j.nbd.2024.106694_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12020181","article-title":"A nuclear magnetic resonance spectroscopy method in characterization of blood metabolomics for Alzheimer's disease","volume":"12","author":"Weng","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.nbd.2024.106694_bb0395","series-title":"Global action plan on the public health response to dementia 2017\u20132025","author":"World Health Organization (WHO)","year":"2017"},{"key":"10.1016\/j.nbd.2024.106694_bb0605","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11011-018-0346-8","article-title":"Nicotinamide ribose ameliorates cognitive impairment of aged and Alzheimer's disease model mice","volume":"34","author":"Xie","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.nbd.2024.106694_bb0610","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.nbd.2024.106694_bb0615","first-page":"5163","article-title":"Nicotinamide phosphoribosyltransferase-related signaling pathway in early Alzheimer's disease mouse models","volume":"20","author":"Xing","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.nbd.2024.106694_bb0620","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s40520-022-02120-0","article-title":"The associations of serum valine with mild cognitive impairment and Alzheimer\u2019s disease","volume":"34","author":"Xiong","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.nbd.2024.106694_bb0625","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2105-15-51","article-title":"Statistical hypothesis testing of factor loading in principal component analysis and its application to metabolite set enrichment analysis","volume":"15","author":"Yamamoto","year":"2014","journal-title":"BMC Bioinformatics."},{"key":"10.1016\/j.nbd.2024.106694_bb0630","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4049\/jimmunol.1801382","article-title":"Low cellular NAD(+) compromises lipopolysaccharide-induced inflammatory responses via inhibiting TLR4 signal transduction in human monocytes","volume":"203","author":"Yang","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2024.106694_bb0635","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neulet.2017.03.027","article-title":"Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease","volume":"647","author":"Yao","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2024.106694_bb0640","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-62703-637-5_14","article-title":"Accurate measurement of nicotinamide adenine dinucleotide (NAD(+)) with high-performance liquid chromatography","volume":"1077","author":"Yoshino","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.nbd.2024.106694_bb0645","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13101459","article-title":"Alteration of metabolic profiles during the progression of Alzheimer's disease","volume":"13","author":"Yu","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.nbd.2024.106694_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085403","article-title":"Cerebral ischemia is exacerbated by extracellular nicotinamide phosphoribosyltransferase via a non-enzymatic mechanism","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996124002948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996124002948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T10:27:30Z","timestamp":1733135250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996124002948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":130,"alternative-id":["S0969996124002948"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106694","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased plasma nicotinamide and altered NAD+ metabolism in glial cells surrounding A\u03b2 plaques in a mouse model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106694"}}